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Introduction
Hepatocellular carcinoma (HCC) is one of the common causes
of cancer death in Asia. Hepatic resection has been established as a
curative treatment for hepatocellular carcinoma. Nevertheless, the
prognosis remains poor because postoperative recurrences fre-
quently occur (50 - 60%).1-3 Such recurrences could originate from
the intrahepatic metastases of the primary HCC4，5 and the
multicentric occurrence of new tumors in the postoperative liver
remnant.6-8 These unique features might be due to underlying liver
diseases such as chronic active hepatitis with hepatitis B and C
viral infection. There were several reports that HCC development
was significantly linked to underlying liver diseases.6，9，10 Shuto et
al.11 suggested that hyperplastic foci (HPF), which are defined as a
focal hepatic parenchymal lesion where the hepatocytes have dense
and small nuclei as well as eosinophilic cytoplasm, was an impor-
tant predictor of recurrence of HCC after hepatic resection.
Therefore, not only HCC tumor factors but also the underlying
liver status should be carefully examined in order to select the op-
timal treatments and also better predict tumor recurrence after
curative resection.
The present study was conducted to clarify the risk factors asso-
ciated with intrahepatic recurrences in HCC patients who under-
went curative hepatic resection by investigating tumor factors, op-
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Background: Hepatocellular carcinoma (HCC) commonly develops in patients with chronic hepatitis. This situation is one of the reasons why
intrahepatic recurrence frequently occurs even after curative resection. There are two different components of such recurrences, which occurs
within 12 months (the early recurrence group) and at more than 12 months after resection (the late recurrence group). The present study was
conducted to clarify the factors contributing to these different types of HCC recurrence.
Methods: Ninety seven patients who underwent curative resection for HCCs were followed for initial recurrence, and predictive factors of re-
currence were examined.
Results: Early and late intrahepatic recurrences developed in 30 and 42 patients, respectively. In the former group, univariate analyses
showed the serum AFP level (>100ng/ml, P=0.045), higher inflammatory activity (Grading) (p=0.048) and status of fibrosis (Staging) (p=0.027)
in non-cancerous liver tissues to be significant risk factors, while the serum AFP level (>100ng/ml) was the only independent risk factor based
on a multivariate analysis (RR: 2.78). In the latter group, only the presence of hyperplastic foci (HPF) was found to be a significant risk factor
(p=0.005). Higher Grading tended to be linked to shorter disease-free survival time, although not significant. In the non-cancerous liver tissues
with HPF, the level of Grading, Staging, and PCNA labeling index was significantly higher (p=0.033, 0.003, 0.040, respectively). Conclusion:
Not only the tumor factors but also the underlying hepatic status including HPF, Grading, and Staging were significant risk factors for
intrahepatic recurrence after curative resection for HCC.
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erative factors, and patient characterization giving special attention
to the underlying status of non-cancerous liver tissues.
Patients and methods
Patients and follow up
Ninety-seven patients underwent curative resection for HCC
was closely followed up for more than 12 months after resection at
Department of Transplant and Digestive Surgery, Nagasaki University
Graduate School of Biomedical Sciences. They included 81 males
and 16 females, with a mean age of 61 years old (range: 20-80).
Twenty-four patients (24.7%) were positive for hepatitis B virus
surface antigen (HBV) only, 48 (49.5%) for hepatitis C virus anti
body (HCV) only, 4 for both (4.1%), and 21 were negative for both.
The serum chemistry and the serum levels of alpha-fetoprotein
(AFP) were measured monthly, and ultrasonography as well as com
puted tomography scan were performed at a 3-month interval.
Magnetic resonance imaging, angiography and liver biopsies were
also performed to make a definitive diagnosis of recurrence, if needed.
Pathological examination
Resected liver specimens were fixed in 10% formaldehyde solu-
tion. After a macroscopic examination, a slice containing the maxi-
mum tumor diameter and other slices of lesions suspicious for me-
tastases or venous invasion were embedded in paraffin. Tissue
sections were stained with hematoxylin and eosin (H & E).
According to the classification of Primary Liver Cancer by the
Liver Cancer Study Group of Japan12, the histological findings of
each tumor were examined regarding the histological stage, the de-
grees of portal venous invasion and hepatic venous invasion as
well as the presence of intrahepatic metastases.
Inflammatory activity (Grading), fibrotic status (Staging) and
hyperplastic foci (HPF) in non-cancerous liver tissues
To classify the degree of hepatic inflammation (hepatitic activ-
ity), we used the Histological Activity Index (HAI) score as de-
scribed by Knodell et al.13 Based on their criteria, the H & E
stained specimens of the non-cancerous liver tissues were exam-
ined and classified into four categories according to Desmet's
method14; G0 (normal, or minimal chronic hepatitis), G1 (mild
chronic hepatitis), G2 (moderate chronic hepatitis), and G3 (severe
chronic hepatitis). To classify fibrosis, Scheuer's method15 were
used. The stage of fibrosis was categorized as F0 (non-fibrosis), F1
(enlarged, fibrotic portal tracts), F2 (fibrosis in periportal or portal-
portal septa, but an intact architecture), F3 (fibrosis with architec-
tural distortion, but not obvious cirrhosis) and F4 (probable or defi-
nite cirrhosis). Figure 1 shows a liver with inflammatory and
fibrotic change (G2 and F3).
Hyperplastic foci (HPF) were defined as a focal hepatic
parenchymal lesion where the hepatocytes have dense and small
nuclei as well as eosinophilic cytoplasm11，16 (Figure 2). The presence
of HPF was examined in H&E-stained specimens of non-cancerous
liver tissues. The liver tissue with at least one lesion of hyperplastic
cells was defined as positive for HPF. The pathological findings
were independently judged by two pathologists (K.K. and S.O.).
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Figure 1. The liver with inflammatory and fibrotic change (G2 and F3).
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Proliferating cell nuclear antigen labeling index (PCNA L.I.)
The labeling index of PCNA was examined according to a
method described in a previous report17, which was determined by
the ratio of PCNA-positive hepatocytes per 1000 hepatocytes.
Statistical analyses
Possible risk factors for early recurrence were compared using
the chi-square test with Yates' correction (or Fisher's exact test
where appropriate) for nominal variables and/or unpaired Student
t test for continuous variables. Risk factors in either the chi-square
or Student t test for early recurrence were consecutively analyzed
based on multivariate logistic regression models. Possible risk fac-
tors for late recurrence were entered into Cox's multivariate pro-
portional hazard model. The cumulative recurrence-free survival
curves were analyzed using the Kaplan-Meier method and then
were compared with the log rank test. A p value of less than 0.05
was considered to be statistically significant.
Results
Figure 3 shows the cumulative recurrence-free survival curve
among 97 patients in the present study. Seventy-two of them (74.2
%) developed intrahepatic recurrence while the remaining 25 had
no recurrence during the follow-up period. Two different compo-
nents were observed in the recurrence-free survival curve. The first
component was rapidly decreased within 12 months after curative
hepatectomy, and these patients were classified as the early recur-
rence group. The second component was slowly decreased thereaf-
ter, and this group was classified as the late recurrence group.
Five patients (5.2 %) developed extra-hepatic recurrence, 7 (7.2
%) underwent a re-resection, and 27 (27.8 %) received chemo-
lipiodolization. The 1-, 3-, and 5-year recurrence-free survival
rates were 69 %, 38 % and 23 %, respectively. The median recur
rence-free survival time was 30.7 months (range: 4.5 - 106.5 months).
Preoperative patient characterization, tumor factors, and operative
factors associated with HCC recurrences are shown in Table 1. The
early and late recurrences developed in 30 and 42 patients, respec-
tively.
Risk factors for early intrahepatic recurrence (Tables 1-3)
Thirty of 72 patients with recurrent HCCs (41.7 %) developed
early intrahepatic recurrence within 12 months after a curative re-
section. The median recurrence-free survival time in the early
phase was 5.9 months. Higher Grading (G2+G3; p=0.048), Staging
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Figure 2. Hyperplastic foci is defined as a focal hepatic parenchymal lesion where the hepatocytes have dense and
small nuclei as well as eosinophilic cytoplasm (in boxes) (x200, x400)
Figure 3. The cumulative recurrence-free survival curve after curative re-
section of HCC. There were two different components as follows; 1) rapid
decrease within 12 months and 2) slow decrease more than 12 months.
months after resection
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(F3+F4; p=0.027), and serum AFP levels (>100ng/ml; p=0.045)
were significant risk factors based on a univariate analysis,
whereas no operative factors were found to be significant. Eleven
of 30 patients suffered from the early recurrence had HPF in the
non-cancerous liver tissues. The presence of HPF was not signifi-
cantly related to the early recurrence. A multivariate analysis dem-
onstrated only the serum AFP levels to be independently signifi-
cant (RR: 2.78).
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Table 1. Differences between early, late, or no recurrence
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Table 2. Univariate analysis for early recurrence































































































Table 3. Multivariate analysis for early recurrence
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Risk factors for late intrahepatic recurrence
Forty-two of 72 patients with recurrent HCCs (58.3 % ) devel-
oped late intrahepatic recurrence and the median recurrence-free
survival time was 46.1 months. Regarding the cumulative recur-
rence-free survival, patients with higher grading (G2+G3) tended
to have a shorter recurrence-free survival time, although the differ-
ence was not statistically significant (Figure 4). On the other hand,
Staging in non-cancerous liver tissues did not affect the late recur-
rence (Figure 4). Twenty-one of 42 patients suffered from the late
recurrence had HPF in the non-cancerous liver tissues. The pres-
ence of HPF was a significant risk factor for the late recurrence
(Table 4, Figure 4), while neither operative factors nor tumor fac-
tors were not significant risk factors for the late recurrence (Table
4). In addition, HPF-positive livers demonstrated not only higher
Grading and Staging but also higher score of PCNA L.I. than those
in HPF-negative livers (Figure 5).
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Figure 4. Relationship of recurrence-free survival time with Grading, Staging, and HPF.
The presence of HPF was significantly related to shorter recurrence-free survival time. Higher Grading (G2+G3)
tended to be associated with shorter recurrence-free survival time, whereas Staging was not associated.
Figure 5. Relationship between HPF and Grading, Staging, PCNA L.I.
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Discussion
In the present study, the recurrence-free survival curve after
curative resection for HCC had different components including the
early recurrence within 12 months after resection and late recur-
rence after more than 12 months. This finding was consistent with
the report by Poon et al.4 In the early recurrence group, a multivari-
ate analysis revealed that the significant risk factor was higher
serum AFP level (>100ng/ml). This finding suggests that tumor
factors such as malignant potential of HCC cells are one of the im-
portant risk factors for the early recurrence.18-20 In addition,
univariate analyses in the risk factors of early recurrence also
showed higher Grading and Staging of non-cancerous liver tissues
to be significant risk factors, suggesting that higher hepatitic activ-
ity also enhanced early intrahepatic recurrence.6 This finding also
suggests that one of the mechanisms for early recurrence is due to
metachronous occurrence of new tumors (multicentric origin, re-
ferred to as MO). However, the rate of intrahepatic recurrence due
to MO is not so high (14 - 25%). 17,21 Therefore, high incidence of
early recurrence in the active hepatitis group (G2+G3, F3+F4)
compared to the other group (G0+G1, F1+F2) could not be ex-
plained by the MO-mechanism alone. It was previously reported
that the expression of vascular adhesion molecules including endo-
thelial leukocyte adhesion molecule-1 (ELAM-1), intercellular ad-
hesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1
and CD-44 in the hepatocytes and/or hepatic sinusoidal lining cells
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Table 4. Analysis for late recurrence by Cox's proportional hazard model
a) A: subsegmentectomy or less; B: segmentectomy; C: lobectomy or more. *significant factor
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was up- regulated in chronic active hepatitis.22，23 These adhesion
molecules, especially ELAM-1, were reported to mediate the adhe-
sion of HepG2 cells and the serum ICAM-1 levels also increased
after a hepatectomy.23 The up-regulation of adhesion molecules and
hepatitic activity could enhance early intrahepatic metastasis from
primary HCCs. Adachi et al.17 reported that hepatic resection espe-
cially in the active hepatitis group might give rise to various grades
of impaired immunity. If HCC cells were spread in the remnant
liver during and/or after resection, it would be easy for them to sur-
vive and proliferate in the liver of patients with such an impaired
immunity. Taking together, early intrahepatic recurrence after
curative resection of HCCs seems to be associated with not only
primary tumor factors but also underlying hepatitic activity.
On the other hand, the significant risk factor for late recurrence
in the present study was only the underlying hepatic status such as
the presence of HPF, but neither primary tumor factors nor opera-
tive factors. The livers with HPF had higher hepatitic activity
(higher Grading, and/or Staging) and higher scores of PCNA L.I.
than HPF-negative ones. Hyperplastic foci are analogous to parts
of adenomatous hyperplasias (AHs) or early HCCs.11 Wakasa et al.24
reported that the proliferative activity of HPF, as expressed accord-
ing to the PCNA L.I., is almost the same as that of AHs and early
HCCs. They also reported that HPF-positive livers had a higher
hepatitic activity and HPF lesions reflected the risk of multicentric
hepato-carcinogenesis. Tarao et al.9 and Koike et al.10 reported that
HCC development was significantly linked to underlying liver dis-
eases with a high degree of DNA synthesis, suggesting that inflam-
matory liver tissues has a potential to develop HCCs. Therefore, it
is possible that HPF itself may be one of the precancerous lesions
in multicentric carcinogenesis.
In conclusions, not only the tumor factors but also the underly-
ing hepatic status including Grading, Staging, and the presence of
HPF were significant risk factors for the intrahepatic recurrence
after curative resection for HCC. To achieve better outcome in
HCC patients after curative resection, anti-hepatitis treatments as
well as anti-tumor treatments during pre- and post-operative phase
should be established.
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